Transdermal compositions containing low molecular weight drugs which are liquid at room temperatures
AssigneeNoven Pharmaceuticals, Inc.
InventorsJuan Mantelle, David Houze
Life of this patent
Estimating the term…
Loading patent…
AssigneeNoven Pharmaceuticals, Inc.
InventorsJuan Mantelle, David Houze
Estimating the term…
A transdermal composition is disclosed which contains a blend of one or more polymers, one or more drugs, at least one of which has a low molecular weight and is liquid at or about room temperatures. The composition is substantially free of water and liquids which have a normal boiling point (a) optionally below processing temperatures and (b) greater than or equal to the temperature of the low molecular weight drugs. The composition does not suffer from the substantial loss of the lower molecular weight drug during production of the transdermal system. A transdermal composition is also disclosed which has one or more drugs, at least one of which has a low molecular weight and is liquid at or about room temperatures, and a polymer matrix including one or more high shear resistant polymers. The high shear resistant polymer(s) reduce the plasticizing effect of the low molecular weight drug, and has sufficient tack and shear for application to a human being.
A transdermal drug delivery system comprising a blend of:
A pressure-sensitive transdermal drug delivery system suitable for transdermal drug delivery comprising a blend of:
A method of producing a pressure-sensitive transdermal drug delivery system suitable for a transdermal drug delivery system, comprising the steps of:
A pressure-sensitive adhesive transdermal drug delivery system suitable for transdermal drug delivery comprising a blend of:
A method of producing a pressure-sensitive transdermal drug delivery system suitable for a transdermal drug delivery system, comprising the steps of:
Dependencies are inferred from the claim text.